An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study. [electronic resource]
Producer: 20021121Description: 1264-74 p. digitalISSN:- 0923-7534
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Burkitt Lymphoma -- drug therapy
- Cyclophosphamide -- therapeutic use
- Cytarabine -- therapeutic use
- Doxorubicin -- therapeutic use
- Drug Evaluation
- Etoposide -- therapeutic use
- Female
- Humans
- Ifosfamide -- therapeutic use
- L-Lactate Dehydrogenase -- metabolism
- Male
- Methotrexate -- therapeutic use
- Middle Aged
- Neoplasm Staging
- Prognosis
- Prospective Studies
- Risk Factors
- Survival Rate
- Treatment Outcome
- United Kingdom
- Vincristine -- therapeutic use
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.